Latest filing published 29 Apr 2022 for Fortress Biotech, Inc., €76k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Robyn Hunter: trading record in brief
All filings by Robyn Hunter on record concern Fortress Biotech, Inc., in the capacity of finance chief. In total, 4 filings cover trades dated from 23 November 2018 to 21 September 2021.
Both buying and selling appear: 1 purchase worth €2,247, against 3 sales worth €205k. Netting one side against the other leaves €203k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings no purchases and 1 sale.
Most recently, on 29 April 2022, the filings show an open-market sale worth €76k in Fortress Biotech, Inc. The most recent open-market purchase was published on 31 December 2019, 2,505 days ago. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robyn Hunter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,292 shares@ US$3.13100.0% of flowCommon Stock, par value $0.001SEC:0001104659-22-053623:0
1 of 1 declaration